
Data from ACC 2018 showed the PCSK9 inhibitor is associated with an absolute risk reduction of 1.6% in treated patients versus placebo.

Data from ACC 2018 showed the PCSK9 inhibitor is associated with an absolute risk reduction of 1.6% in treated patients versus placebo.

A healthy plant-based diet can reduce a person's risk of developing CKD by 14% and can also help slow the decline of kidney function, according to a new study.

A 27-year study found that signs of oral infections in childhood were associated with cardiovascular risk factors and subclinical atherosclerosis in adulthood.

New COMMANDER HF post hoc data shows more evidence the blood-thinning therapy has some effect on potentially deadly cardiovascular events.

Investigators found that 2 months of antibiotic use later in life could result in a 32% increase in likelihood of developing a cardiovascular disease.

The Connected MOM program allows self-monitoring during pregnancy so that some in-person visits can be skipped, and any issues can be identified early.

A new study of 55 million insured young adults in the US found that major depression, type 2 diabetes, and other conditions are becoming more prevalent among them.

The LOTUS Edge Aortic Valve System was approved in Europe just 1 month ago, and will be available in the US the following weeks.

The TransPyloric Shuttle device is delivered endoscopically to the stomach and can be used for up to 12 months of treatment.

The Apple Watch-friendly platform is the first cleared by the FDA to detect and report the 3 common arrhythmias, including atrial fibrillation.

Investigators found that a plant-based diet was associated with a 41% reduction in heart failure risk, while a “southern” diet heavy in fried food, added fats, and eggs was associated with a 72% increase in risk.

Investigators found that participants who never ate breakfast were 87% more likely to die from cardiovascular disease and stroke than those who ate breakfast every day.

Years of real-world assessment have given cardiologists a good idea of what's optimal for patients with AF.

Richard Milani, MD, shares about the digital medicine program, particularly the track for patients with hypertension.

Aimee Quirk, CEO of innovationOchsner shares about how they have improved aspects of health care by introducing uses of technology.

LDL cholesterol increases the risk of heart disease and ischemic stroke, but in patients with very low levels of “bad cholesterol,” hemorrhagic stroke may actually increase.

Is there an improved method of care for patients at risk of losing limbs?

What were the findings of a large, single-center registry assessment for inflammation in patients with low LDL-C?

The daily oral capsule was shown to reduce overweight and obese patient weight by about 6% over 6 months.

Fewer heart disease-related deaths occur in counties where Medicaid was expanded under the Affordable Care Act, according to a provocative new study.

Additionally, the added sugar labels will save the health care system an estimated $31 billion.

About 4 million Americans can’t tolerate statins. A new study suggests bempedoic acid could be used to help these patients lower their LDL cholesterol.

The CREDENCE study of canagliflozin in adults with chronic kidney disease and type 2 diabetes met its primary endpoint as well as cardiovascular endpoints.

Time-restricted feeding has been shown in early trials to be a beneficial treatment for various cardiovascular disease risk metrics.

Study finds that, despite the creation of the Hospital Readmissions Reduction Program, US and Canada saw similar declines in HF readmission rates.